Event

Significant Changes to the 12th Edition of Standards for Cellular Therapy Services (25EL-537)

Please note: AABB reserves the right to make updates to this program.

Wednesday, May 21, 2025
2:00 – 3:00 PM Eastern Time
Program Number: 25EL-537

  • Educational Track: Quality Education
  • Topic: Biotherapies
  • Intended Audience: CEOs, CFOs, COOs, Directors, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Scientists, Technologists
  • Teaching Level: Basic
  • Director/Moderator: Christopher Bocquet, Senior Director, Standards Development and Quality Initiatives, AABB, Bethesda, MD
    Speakers:

    • Kate Brown, PhD, Senior Director, Science, CooperSurgical, Tucson, AZ
    • Yvette Tanhehco, PhD, MD, MS, CABP, Associate Professor of Pathology and Cell Biology, Medical Director of Cellular Therapy Laboratory, Assistant Medical Director of Transfusion Medicine, Columbia University Irving Medical Center, New York, NY
  • Program Description

    This program will introduce the 12th Edition of AABB Standards for Cellular Therapy Services. The speakers will summarize the new and revised requirements incorporated into the 12th Edition of Standards. In addition, the rationale for the changes will be presented and reviewed.

    Learning Objectives

    After participating in this educational activity, participants should be able to:

    • Explain the rationale for revised requirements.
    • Identify ways to implement the new and revised requirements.
    • Identify existing policies, processes, and procedures that may need to be changed to conform to the 12th Edition of Standards.

    Registration

    Registration includes access to both the live and on-demand version of this eCast.

    If you are a facility interested in participating in this eCast, simply complete the Group Viewing registration form and AABB will provide detailed instructions to share with your team approximately one week prior to the live program (each team member to register for the program utilizing a promocode). For single viewers, simply click on the Register button below to register.

    Please note: registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time, you will receive access to the on-demand eCast when it is available.

    Single ViewerRegister
    Group ViewingRegister

    Continuing Education Credit

    This activity is eligible for one (1) continuing education credit/contact hour for Nurses (including California-based nursing professionals through CBRN), California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.

    There is no financial support for this activity.

    Claiming Credit
    Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.

    Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).

    Program & Credit Expiration Dates:

    • Live Activity Program Date: May 21, 2025; Credit Expiration Date: June 21, 2025
    • Enduring Activity Program Dates: May 21, 2025 – May 20, 2028; Credit Expiration Date: May 20, 2028

    Disclosure Declaration

    Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and CME Outfitters, LLC. personnel are provided at the beginning of the program.

    Faculty Biographies

    Christopher BocquetChristopher Bocquet serves as the Senior Director for Standards and Quality Initiatives at AABB. In this role, Chris oversees all AABB Standards Committees as they work to create new editions of AABB Standards and associated Guidance documents.



    Dr. Kate BrownDr. Kate Brown, Chair of the Cell Therapy Standards Committee, is the Senior Director of Science at Generate Life Sciences, a Cooper Surgical company. Dr. Brown earned her PhD in Molecular and Cell Biology from the University of California, Berkeley and her Bachelor’s degree from the University of Colorado, Boulder. Dr. Brown has been with Cord Blood Registry, an affiliate of Generate Life Sciences and the world’s largest private newborn stem cell bank, for more than a decade. In her current capacity, Dr. Brown is responsible for the scientific direction and tactical execution of Generate Life Science’s Research and Development portfolio to support the clinical translation of various perinatal stem cell populations and advancing a variety of Science and Technology projects throughout Generate Life Sciences.


    Dr. Yvette C. TanhehcoDr. Yvette C. Tanhehco, is an Associate Professor of Pathology and Cell Biology at Columbia University Irving Medical Center (CUIMC) and the Medical Director of the Cellular Therapy Laboratory and Assistant Director of Transfusion Medicine at New York-Presbyterian Hospital/CUIMC. She obtained a Bachelor of Arts degree in Microbiology and Molecular and Cell Biology from Cornell University; a Doctor of Philosophy degree in viral oncology from Johns Hopkins University; a Medical degree from the University of Pittsburgh; and a Masters of Science degree in Translational Research from the University of Pennsylvania. She completed both her residency training in Clinical Pathology and fellowship training in Blood Banking/Transfusion Medicine at the Hospital of the University of Pennsylvania. She has been involved in the field of biotherapies since 2012 and an active member of AABB’s cellular therapy standards committee since 2022.